Publication:
Anti-Hav Total Prevalence in Inactive Hepatitis B Carriers and in Patients with Chronic Hepatitis B, C and D

dc.authorwosidAtaman Hati̇poğlu, Çiğdem/Aaa-4135-2021
dc.authorwosidTulek, Necla/M-3283-2017
dc.authorwosidErtem, Gunay/Grj-7397-2022
dc.authorwosidYetkin, Meltem/Gqb-0055-2022
dc.authorwosidKinikli, Sami/Iyj-9555-2023
dc.authorwosidAtaman Hatipoğlu, Çiğdem/Aaa-4135-2021
dc.contributor.authorHatipoglu, Cigdem Ataman
dc.contributor.authorKinikli, Sami
dc.contributor.authorKoruk, Suda Tekin
dc.contributor.authorArica, Nese Ates
dc.contributor.authorErtem, Gunay Tuncer
dc.contributor.authorYetkin, M. Arzu
dc.contributor.authorDemiroz, Ali Pekcan
dc.contributor.authorIDAtaman Hati̇poğlu, Çiğdem/0000-0002-1104-8232
dc.contributor.authorIDTuncer Ertem, Gunay/0000-0001-8760-0030
dc.date.accessioned2025-12-11T01:21:59Z
dc.date.issued2005
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Hatipoglu, Cigdem Ataman; Kinikli, Sami; Koruk, Suda Tekin; Arica, Nese Ates; Ertem, Gunay Tuncer; Yetkin, M. Arzu; Demiroz, Ali Pekcan] SB Ankara Egitim & Arafltirma Hastanesi, Nfeksiyon Hastaliklari & Klin Mikrobiyoloji Klin, Ankara, Turkey; [Tulek, Necla] Ondokuz Mayis Univ, Tip Fak, Nfeksiyon Hastaliklari &Klin Mikrobiyoloji Anabil, Samsun, Turkeyen_US
dc.descriptionAtaman Hati̇poğlu, Çiğdem/0000-0002-1104-8232; Tuncer Ertem, Gunay/0000-0001-8760-0030;en_US
dc.description.abstractHepatitis A virus (HAV) infection is a worldwide health problem, but rarely causes fatal fulminan hepatitis. HAV infection in patients with chronic liver diseases is associated with increased rate of fulminan hepatitis and mortality. Vaccination against HAV is recommended for patients with underlying chronic liver disease who are negative for anti-HAV antibody. In this study, a total of 780 patients (680 inactive hepatitis B virus carrier, 62 chronic hepatitis C, 34 chronic hepatitis B, 4 chronic hepatitis D) were tested for the presence of anti-HAV total antibody. Anti-HAV seroprevalence was found 93.7%.en_US
dc.description.woscitationindexEmerging Sources Citation Index
dc.identifier.endpage168en_US
dc.identifier.issn1307-9441
dc.identifier.issn2147-2939
dc.identifier.issue3en_US
dc.identifier.startpage164en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/43276
dc.identifier.volume10en_US
dc.identifier.wosWOS:000217138900007
dc.language.isotren_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofViral Hepatit Dergisi-Viral Hepatitis Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis A Virus Infectionen_US
dc.subjectSeroprevalenceen_US
dc.subjectChronic Viral Hepatitisen_US
dc.titleAnti-Hav Total Prevalence in Inactive Hepatitis B Carriers and in Patients with Chronic Hepatitis B, C and Den_US
dc.typeArticleen_US
dspace.entity.typePublication

Files